C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 38, 2009, Pages 16157-16162

  Teesalu, Tambet ^a   Sugahara, Kazuki N ^a   Kotamraju, Venkata Ramana ^a   Ruoslahti, Erkki ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Cell penetrating peptides; Homing peptides; Vascular permeability; VEGF

Indexed keywords

ARGININE; NANOPARTICLE; NEUROPILIN 1; PROTEINASE; VASCULOTROPIN 165;

AFFINITY CHROMATOGRAPHY; AMIDATION; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BACTERIOPHAGE; BLOOD VESSEL PERMEABILITY; CANCER CELL; CARBOXY TERMINAL SEQUENCE; INTERNALIZATION; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION;

AMINO ACID SEQUENCE; ANIMALS; ARGININE; BINDING SITES; BINDING, COMPETITIVE; CELL LINE, TUMOR; CHROMATOGRAPHY, AFFINITY; ENDOCYTOSIS; HUMANS; LUNG; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, CONFOCAL; NEOPLASM TRANSPLANTATION; NEUROPILIN-1; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PEPTIDES; PROSTATIC NEOPLASMS; PROTEIN BINDING; TISSUE DISTRIBUTION; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349482671     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0908201106     Document Type: Article

References (37)

1. Joliot A, Pernelle C, Deagostini-Bazin H, Prochiantz A (1991) Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci USA 88:1864-1868. (Pubitemid 21916327)
2. Elliott G, O'Hare P (1997) Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88:223-233. (Pubitemid 28015871)
3. Green M, Loewenstein PM (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55:1179-1188. (Pubitemid 19020070)
4. Frankel AD, Pabo CO (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189-1193. (Pubitemid 19020071)
5. Langel Ü (2007) Handbook of Cell-Penetrating Peptides (CRC/Taylor & Francis, Boca Raton).
6. Laakkonen P, Porkka K, Hoffman JA, Ruoslahti E (2002) A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat Med 8:751-755. (Pubitemid 34778730)
7. Porkka K, Laakkonen P, Hoffman JA, Bernasconi M, Ruoslahti E (2002) A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo. Proc Natl Acad Sci USA 99:7444-7449. (Pubitemid 34568710)
8. Hoffman JA, et al. (2003) Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell 4:383-391.
9. Järvinen TA, Ruoslahti E (2007) Molecular changes in the vasculature of injured tissues. Am J Pathol 171:702-711.
10. Jiang T, et al. (2004) Tumor imaging by means of proteolytic activation of cellpenetrating peptides. Proc Natl Acad Sci USA 101:17867-17872. (Pubitemid 40051978)
11. Michel CC (1996) Transport of macromolecules through microvascular walls. Cardiovasc Res 32:644-653. (Pubitemid 26332304)
12. Rabbani ML, Rogers PA (2001) Role of vascular endothelial growth factor in endometrial vascular events before implantation in rats. Reproduction 122:85-90. (Pubitemid 32677151)
13. Maeda H, Fang J, Inutsuka T, Kitamoto Y (2003) Vascular permeability enhancement in solid tumor: Various factors, mechanisms involved and its implications. Int Immunopharmacol 3:319-328. (Pubitemid 36293960)
14. Baban DF, Seymour LW (1998) Control of tumour vascular permeability. Adv Drug Deliv Rev 34:109-119.
15. Senger DR, et al. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985.
16. Ferrara N, Henzel WJ (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858. (Pubitemid 19162712)
17. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669-676.
18. Takashima S, et al. (2002) Targeting of bothmouseneuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci USA 99:3657-3662. (Pubitemid 34252162)
19. Staton CA, Kumar I, Reed MWR, Brown NJ (2007) Neuropilins in physiological and pathological angiogenesis. J Pathol 212:237-248.
20. Becker PM, et al. (2005) Neuropilin-1 regulates vascular endothelial growth factormediated endothelial permeability. Circ Res 96:1257-1265.
21. Acevedo LM, Barillas S, Weis SM, Göthert JR, Cheresh DA (2008) Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood 111:2674-2680.
22. Jia H, et al. (2006) Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling. J Biol Chem 281:13493-13502. (Pubitemid 43855262)
23. Starzec A, et al. (2006) Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Life Sci 79:2370-2381. (Pubitemid 44772930)
24. Hoffman JA, Laakkonen P, Porkka K, Bernasconi M, Ruoslahti E (2004) In vivo and ex vivo selections using phage-displayed libraries. Phage Display: A Practical Approach, eds Clackson T, Lowman HB (Oxford Univ Press, Oxford), Chap 10.
25. Wadia JS, Dowdy SF (2002) Protein transduction technology. Curr Opin Biotech 13:52-56.
26. Gammon ST, Villalobos VM, Prior JL, Sharma V, Piwnica-Worms D (2003) Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: Chiral and sequence-specific effects on net cell uptake. Bioconjug Chem 14:368-376. (Pubitemid 36348660)
27. Cheresh DA, Spiro RC (1987) Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem 262:17703-17711. (Pubitemid 18032258)
28. Vander Kooi CW, et al. (2007) Structural basis for ligand and heparin binding to neuropilin B domains. Proc Natl Acad Sci USA 104:6152-6157.
29. Hong TM, et al. (2007) Targeting neuropilin 1 as an antitumor strategy in lung cancer. Clin Cancer Res 13:4759-4768. (Pubitemid 47294782)
30. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735-745. (Pubitemid 28155313)
31. von Wronski MA, et al. (2006) Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor. J Biol Chem 281:5702-5710.
32. Starzec A, et al. (2007) Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex. Peptides 28:2397-2402. (Pubitemid 350116304)
33. Mamluk R, Klagsbrun M, Detmar M, Bielenberg DR (2005) Soluble neuropilin targeted to the skin inhibits vascular permeability. Angiogenesis 8:217-227. (Pubitemid 41759146)
34. Jia H, et al. (2001) Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis. Biochem Biophys Res Commun 283:469-479. (Pubitemid 32924715)
35. Dvorak AM, Feng D (2001) The vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelle. J Histochem Cytochem 49:419-432.
36. Basu A, Chaturvedi UC (2008) Vascular endothelium: The battlefield of dengue viruses. FEMS Immunol Med Microbiol 53:287-299.
37. Weis SM (2008) Vascular permeability in cardiovascular disease and cancer. Curr Opin Hematol 15:243-249.